<DOC>
	<DOC>NCT02889653</DOC>
	<brief_summary>The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.</brief_summary>
	<brief_title>The Bleeding With Antithrombotic Therapy Study 2</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients with cerebrovascular or cardiovascular diseases who start or continue taking oral antithrombotics (antiplatelets and/or anticoagulants) to prevent vascular events Patients who are able to receive MRI Provision of written informed consent either directly or by a suitable surrogate MRI contraindication Any condition that in the opinion of the responsible physician or investigator that renders the patient unsuitable for the study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>